Sino-Agri Leading Biosciences Co.,Ltd (SHA:603970)
China · Delayed Price · Currency is CNY 13.21
-0.15 (-1.12%)
Apr 30, 2026, 3:00 PM CST
SHA:603970 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,363 | 11,241 | 10,596 | 10,460 | 11,699 | 8,822 | |
Revenue Growth (YoY) | 5.89% | 6.09% | 1.30% | -10.59% | 32.61% | 32.84% |
Cost of Revenue | 10,621 | 10,501 | 9,878 | 9,758 | 10,972 | 8,292 |
Gross Profit | 742.03 | 739.8 | 718.27 | 701.54 | 726.8 | 530.36 |
Selling, General & Admin | 325.97 | 326.63 | 321.85 | 320.13 | 294.73 | 248.88 |
Research & Development | 61.77 | 65.33 | 66.74 | 65.36 | 45.79 | 37.53 |
Other Operating Expenses | 0.3 | -0.1 | 0.04 | 6.88 | 9.38 | 10.58 |
Operating Expenses | 388.04 | 391.86 | 406.51 | 420.26 | 352.43 | 295.38 |
Operating Income | 354 | 347.94 | 311.76 | 281.28 | 374.37 | 234.99 |
Interest Expense | - | - | -22.44 | -16.6 | -26.76 | -33.84 |
Interest & Investment Income | 2.46 | 2.1 | 18.45 | 39.66 | 28.65 | 66.55 |
Currency Exchange Gain (Loss) | - | - | -0.03 | -16.22 | -15.19 | 13.87 |
Other Non Operating Income (Expenses) | -113.06 | -111.84 | -11.3 | 2.09 | -29.78 | -8.65 |
EBT Excluding Unusual Items | 243.4 | 238.2 | 296.43 | 290.21 | 331.3 | 272.92 |
Gain (Loss) on Sale of Investments | 23.14 | 20.18 | 1.26 | 11.83 | -18.55 | -13.55 |
Gain (Loss) on Sale of Assets | -0.52 | -0.36 | -0.58 | 0.71 | -0.77 | 0.3 |
Asset Writedown | -24.65 | -18.61 | -0.02 | -0.24 | 0.29 | -27.19 |
Other Unusual Items | - | - | 5.01 | 12.62 | 13.42 | 7.76 |
Pretax Income | 241.37 | 239.42 | 302.11 | 315.13 | 325.69 | 240.24 |
Income Tax Expense | 54.93 | 53.3 | 73.23 | 67.55 | 77.8 | 54.6 |
Earnings From Continuing Operations | 186.43 | 186.12 | 228.87 | 247.58 | 247.89 | 185.64 |
Minority Interest in Earnings | -12.91 | -13.59 | -25.5 | -22.74 | -37.57 | -15.33 |
Net Income | 173.52 | 172.53 | 203.38 | 224.84 | 210.32 | 170.31 |
Net Income to Common | 173.52 | 172.53 | 203.38 | 224.84 | 210.32 | 170.31 |
Net Income Growth | -13.45% | -15.17% | -9.55% | 6.91% | 23.49% | 28.59% |
Shares Outstanding (Basic) | 269 | 269 | 269 | 269 | 269 | 269 |
Shares Outstanding (Diluted) | 269 | 269 | 269 | 269 | 269 | 269 |
Shares Change (YoY) | 0.01% | -0.01% | 0.01% | -0.01% | 0.00% | -0.01% |
EPS (Basic) | 0.65 | 0.64 | 0.76 | 0.84 | 0.78 | 0.63 |
EPS (Diluted) | 0.65 | 0.64 | 0.76 | 0.84 | 0.78 | 0.63 |
EPS Growth | -13.46% | -15.16% | -9.55% | 6.92% | 23.48% | 28.60% |
Free Cash Flow | 505.03 | -79.68 | 305.21 | -948.57 | 1,532 | 321.43 |
Free Cash Flow Per Share | 1.88 | -0.30 | 1.14 | -3.53 | 5.70 | 1.20 |
Dividend Per Share | - | - | 0.450 | 0.450 | 0.393 | 0.250 |
Dividend Growth | - | - | - | 14.53% | 57.16% | 16.66% |
Gross Margin | 6.53% | 6.58% | 6.78% | 6.71% | 6.21% | 6.01% |
Operating Margin | 3.12% | 3.09% | 2.94% | 2.69% | 3.20% | 2.66% |
Profit Margin | 1.53% | 1.54% | 1.92% | 2.15% | 1.80% | 1.93% |
Free Cash Flow Margin | 4.45% | -0.71% | 2.88% | -9.07% | 13.10% | 3.64% |
EBITDA | 363.75 | 357.75 | 321.83 | 292.15 | 387.06 | 245.14 |
EBITDA Margin | 3.20% | 3.18% | 3.04% | 2.79% | 3.31% | 2.78% |
D&A For EBITDA | 9.75 | 9.81 | 10.07 | 10.87 | 12.68 | 10.15 |
EBIT | 354 | 347.94 | 311.76 | 281.28 | 374.37 | 234.99 |
EBIT Margin | 3.12% | 3.09% | 2.94% | 2.69% | 3.20% | 2.66% |
Effective Tax Rate | 22.76% | 22.26% | 24.24% | 21.44% | 23.89% | 22.73% |
Revenue as Reported | - | - | 10,596 | 10,460 | 11,699 | 8,822 |
Advertising Expenses | - | - | 55.36 | 48.03 | 40.44 | 25.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.